ABSTRACT
Background Weight loss observed in clinical trials has failed to translate into real world clinical settings. The objective of the current review was to quantify patient weight loss using various approaches tested in primary care and to unveil relevant contextual factors that could improve patient weight loss on a long-term basis.
Methods Data were compiled from Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE, Scopus, and Web of Science from inception to October 30, 2022. Only randomized clinical trials conducted in people with overweight or obesity in a primary care setting where the intervention was administered by a primary care provider for at least 6 months were included. All investigators identified studies and independently abstracted data using COVIDENCE systematic review software. Quality assessment and risk of bias of individual studies was assessed in the context of the primary outcome using the template provided by COVIDENCE.
Results The seven studies included 2,187 people with obesity who had weight-related comorbidities or risk factors. Substantial heterogeneity in the outcomes was observed, as well as bias toward lack of published studies showing no effect. The random effect model estimated a treatment effect for the aggregate efficacy of primary care interventions −3.54 kg (95% CI: - 5.61 kg to −1.47 kg). Interventions that included a medication component (alone or as part of a multipronged intervention) achieved a greater weight reduction by −2.94 kg (p<0.0001). In all interventions, efficacy declined with time (reduction in weight loss by 0.53 kg per six months, 95%CI: 0.04-1.0 kg, p-value=0.04).
Discussion Weight loss interventions administered by a primary care provider can lead to modest weight loss. Weight loss is approximately doubled if anti-obesity medication is part of the treatment strategy. Nevertheless, weight loss is attenuated over time and underscores the need for long-term treatment.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
PROPERO registration # CRD42021242344
Funded by: 1R18DK127003
Updated discussion
Data Availability
Data and code are provided as a supplement to the paper.
